PMID
Cmpds
Data
Article Title
Organization
20
An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold.

University of Kwazulu-Natal
5
MLN8054 and Alisertib (MLN8237): Discovery of Selective Oral Aurora A Inhibitors.

Takeda Pharmaceutical
39
Ion channels as therapeutic targets: a drug discovery perspective.

Pfizer
3
Allyl m-trifluoromethyldiazirine mephobarbital: an unusually potent enantioselective and photoreactive barbiturate general anesthetic.

Massachusetts General Hospital
44
Selective influence on contextual memory: physiochemical properties associated with selectivity of benzodiazepine ligands at GABAA receptors containing the alpha5 subunit.

Moltech
1
Synthesis of fluorine substituted pyrazolopyrimidines as potential leads for the development of PET-imaging agents for the GABAA receptors.

Abx Advanced Biochemical Compounds
47
2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.

University of Urbino
3
Condensation of muscimol or thiomuscimol with aminopyridazines yields GABA-A antagonists.

Centre De Neurochimie Du Cnrs
15
Exploring subtype selectivity and metabolic stability of a novel series of ligands for the benzodiazepine binding site of the GABAA receptor.

Novartis Institutes For Biomedical Research
3
Azaflavones compared to flavones as ligands to the benzodiazepine binding site of brain GABA(A) receptors.

Lund University
2
A conformational study of ligands for omega modulatory sites of GABAa receptors by NOESY NMR spectroscopy and distance geometry

TBA
16
Identification of anxiolytic/nonsedative agents among indol-3-ylglyoxylamides acting as functionally selective agonists at the gamma-aminobutyric acid-A (GABAA) alpha2 benzodiazepine receptor.

Universita Di Pisa
7
Synthesis of GABAA receptor agonists and evaluation of their alpha-subunit selectivity and orientation in the GABA binding site.

Johannes Gutenberg University
3
Proximity-accelerated chemical coupling reaction in the benzodiazepine-binding site of gamma-aminobutyric acid type A receptors: superposition of different allosteric modulators.

University of Bern
2
Identification of anesthetic binding sites on human serum albumin using a novel etomidate photolabel.

Imperial College
21
A Molecular Toolbox of Positron Emission Tomography Tracers for General Anesthesia Mechanism Research.

Xiamen University
17
Insights into the medicinal chemistry of heterocycles integrated with a pyrazolo[1,5-

Prince Sattam Bin Abdulaziz University
38
Novel imidazo[1,5-a]quinoxaline derivatives: SAR, selectivity and modeling challenges en route to the identification of an α5-GABAA receptor NAM.

Gedeon Richter
173
β-Carboline as a Privileged Scaffold for Multitarget Strategies in Alzheimer's Disease Therapy.

Univ. Grenoble Alpes
3
Pharmacological Analysis of the Anti-inflammatory and Antiallodynic Effects of Zinagrandinolide E from

Universidad Nacional Aut£Noma De M£Xico
32
Synthesis and biological evaluation of 7,8,9,10-tetrahydroimidazo[1,2-c]pyrido[3,4-e]pyrimdin-5(6H)-ones as functionally selective ligands of the benzodiazepine receptor site on the GABA(A) receptor.

Neurogen
56
Imidazopyridine-based selective and multifunctional ligands of biological targets associated with psychiatric and neurodegenerative diseases.

Palack£
32
Subtype Selective γ-Aminobutyric Acid Type A Receptor (GABA

University of Sussex
18
Progress in the discovery of small molecule modulators of the Cys-loop superfamily receptors.

Amgen
21
An overview of benzo[b]thiophene-based medicinal chemistry.

Jain University
1
DEUTERATED COMPOUNDS

Neurocrine Biosciences
27
KISSPEPTIN RECEPTOR (KISS1R) TARGETED THERAPEUTICS AND USES THEREOF

Radionetics Oncology
61
COMPOUNDS HAVING A T-STRUCTURE FORMED BY AT LEAST FOUR CYCLES FOR USE IN THE TREATMENT OF CANCER AND OTHER INDICATIONS

TheRas
320
METHODS FOR TREATMENT OF CANCER

Frontier Medicines
31
SUBSTITUTED TRIAZOLOHETEROARYL COMPOUNDS AS USP1 INHIBITORS AND THE USE THEREOF

Impact Therapeutics (Shanghai)
128
SPIROCYCLIC MODULATORS OF CHOLESTEROL BIOSYNTHESIS AND THEIR USE FOR PROMOTING REMYELINATION

Genentech
97
Substituted benzamides as RIPK2 inhibitors for treatment of inflammatory bowel disease

Boehringer Ingelheim International
26
THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS

Terns Pharmaceuticals
43
N2,N4-diphenylpyrimidine-2,4-diamine derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of cancer

Korea Research Institute of Chemical Technology
51
Substituted-3H-imidazo[4,5-c]pyridine and 1H-pyrrolo[2,3-c]pyridine series of novel Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) and stimulator for interferon genes (STING) modulators as cancer immunotherapeutics

Stingray Therapeutics
7
Substituted cyanopyrrolidines with activity as DUB inhibitors

Mission Therapeutics
52
Heterocyclic inhibitors of monocarboxylate transporter

The Scripps Research Institute
135
Aminoindane-, aminotetrahydronaphthalene- and aminobenzocyclobutane-derived PRMT5-inhibitors

Ctxt
80
Pyridine derivatives

Astellas Pharma
13
Preparation and use of 7a-heterocycle substituted-6,6-difluoro bicyclic himbacine derivatives as PAR-1 receptor antagonists

Merck Sharp & Dohme
46
N-benzoate group substituted benzopyrroline-2-one derivative and use thereof

Beijing Hanmi Pharmaceutical
129
Cyclopropylamines as LSD1 inhibitors

Incyte
18
Methods of use of cyclopamine analogs

Infinity Pharmaceuticals
167
Oxadiazolopyridine derivatives for use as ghrelin O-acyl transferase (GOAT) inhibitors

Boehringer Ingelheim International
170
Compounds and compositions for inhibiting the activity of SHP2

Novartis
60
Tricyclic heterocyclic compounds useful as inhibitors of TNF

Bristol Myers Squibb
80
Aromatic heterocyclic compound

Mitsubishi Tanabe Pharma
63
Heteroaromatic compounds as BTK inhibitors

Boehringer Ingelheim International
31
2-pyridyloxy-3-ester-4-ether orexin receptor antagonists

Merck Sharp & Dohme
44
Factor XIa inhibitors

Merck Sharp & Dohme
130
Urea and amide derivatives of aminoalkylpiperazines and use thereof

Southern Research Institute
6
N-acyl-(3-substituted)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders

Ogeda
147
8-(piperazin-1-yl)-1,2,3,4-tetrahydro-isoquinoline derivatives

Idorsia Pharmaceuticals
63
Styryl quinazoline derivatives as pharmaceutically active agents

Vichem Chemie Kutató
43
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors

Oryzon Genomics
57
1, 3, 4-thiadiazole compounds and their use in treating cancer

AstraZeneca
2
Compounds as rearranged during transfection (RET) inhibitors

Glaxosmithkline
14
Benzimidazole derivatives as RLK and ITK inhibitors

Principia Biopharma
166
Compounds, compositions, and methods

Denali Therapeutics
66
Pyridazinone compounds and their use as DAAO inhibitors

Takeda Pharmaceutical
36
Identification of stabilizers of multimeric proteins

The Leland Stanford Junior University
37
Bicyclic heterocycles as FGFR4 inhibitors

Incyte
352
Heterocyclylamines as PI3K inhibitors

Incyte Holdings
10
Chymase inhibitors

Boehringer Ingelheim International
8
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Merck Sharpe & Dohme
14
Method of treating COVID-19

Pfizer
15
Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase.

The Scripps Research Institute
2
Identification of RIP1 kinase as a specific cellular target of necrostatins.

Tufts University
6
Splicing factor SF3b as a target of the antitumor natural product pladienolide.

Eisai
33
Correlating solution binding and ESI-MS stabilities by incorporating solvation effects in a confined cucurbit[8]uril system.

University of Cambridge
92
Chiral Recognition Thermodynamics of β-Cyclodextrin: The Thermodynamic Origin of Enantioselectivity and the Enthalpy-Entropy Compensation Effect

Japan Science and Technology Agency
19
Discovery of a series of acrylic acids and their derivatives as chemical leads for selective EP3 receptor antagonists.

Ono Pharmaceutical
70
Antagonists of the human A(2A) receptor. Part 6: Further optimization of pyrimidine-4-carboxamides.

Vernalis (R&D)
17
Design, synthesis, and X-ray crystal structures of 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors.

Duquesne University
84
Discovery and structure-activity relationship analysis of Staphylococcus aureus sortase A inhibitors.

University of California Los Angeles
21
Identification of 2-aminobenzimidazoles as potent melanin-concentrating hormone 1-receptor (MCH1R) antagonists.

Banyu Pharmaceutical
24
Second generation of BACE-1 inhibitors part 3: Towards non hydroxyethylamine transition state mimetics.

Gsk
14
N-aryl-oxazolidin-2-imine muscle selective androgen receptor modulators enhance potency through pharmacophore reorientation.

Bristol Myers Squibb
37
Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis.

Kochi Medical School
59
Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins.

Sapienza University of Rome
20
Chalcones: a valid scaffold for monoamine oxidases inhibitors.

Sapienza University of Rome
17
Structure-based design, synthesis, and characterization of inhibitors of human and Plasmodium falciparum dihydroorotate dehydrogenases.

University of Leeds
24
Synthesis of small molecule inhibitors of the orphan nuclear receptor steroidogenic factor-1 (NR5A1) based on isoquinolinone scaffolds.

Scripps Florida
54
Synthesis and SAR of tolylamine 5-HT6 antagonists.

Pfizer
48
Cdc7 kinase inhibitors: pyrrolopyridinones as potential antitumor agents. 1. Synthesis and structure-activity relationships.

Nerviano Medical Sciences
12
Synthesis and SAR of potent LXR agonists containing an indole pharmacophore.

Gsk
35
Pharmacophore guided discovery of small-molecule human apurinic/apyrimidinic endonuclease 1 inhibitors.

University of Southern California
7
The molecular interactions of buspirone analogues with the serotonin transporter.

National Medicines Institute
25
Design and synthesis of 2-amino-pyrazolopyridines as Polo-like kinase 1 inhibitors.

Sunesis Pharmaceuticals
30
Inhibitors of the tyrosine kinase EphB4. Part 1: Structure-based design and optimization of a series of 2,4-bis-anilinopyrimidines.

AstraZeneca
21
Pharmacological and functional comparison of the polo-like kinase family: insight into inhibitor and substrate specificity.

Abbott Laboratories